Charmacy Pharmaceutical Co (HKSE:02289) Change In Receivables : HK$-107 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Change In Receivables?

Charmacy Pharmaceutical Co's change in receivables for the quarter that ended in Dec. 2023 was HK$-146 Mil. It means Charmacy Pharmaceutical Co's Accounts Receivable increased by HK$146 Mil from Jun. 2023 to Dec. 2023 .

Charmacy Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-107 Mil. It means Charmacy Pharmaceutical Co's Accounts Receivable increased by HK$107 Mil from Dec. 2022 to Dec. 2023 .

Charmacy Pharmaceutical Co's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$1,052 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Charmacy Pharmaceutical Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 82.22.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Charmacy Pharmaceutical Co's liquidation value for the six months ended in Dec. 2023 was HK$-991 Mil.

Charmacy Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Change In Receivables Chart

Charmacy Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.91

-187.33

-67.11

-248.43

-107.38

Charmacy Pharmaceutical Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial														121.13	-282.45	20.65	38.68	-146.06

Charmacy Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-107 Mil.

Charmacy Pharmaceutical Co (HKSE:02289) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Charmacy Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1051.908	/	2334.736	*	91
=	82.22

2. In Ben Graham's calculation of liquidation value, Charmacy Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Charmacy Pharmaceutical Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	693.671	-	2898.349	+	0.75 * 1051.908	+	0.5 * 848.6
=	-991

Charmacy Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Charmacy Pharmaceutical Co (HKSE:02289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

https://www.chmyy.com

Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes diversified pharmaceutical products to pharmaceutical distributors, retail pharmacies, hospitals, clinics, and health centers. The company's distribution network covers Southern China and surrounding areas including Fujian province. The firm offers Western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices, cosmetic products, and others. All the group's operations are located in China.

Charmacy Pharmaceutical Co (HKSE:02289) Headlines

No Headlines